VIVUS TO RAISE $12 MILLION IN REGISTERED DIRECT OFFERING OF COMMON STOCK

Vivus, Inc., a pharmaceutical company dedicated to the development and commercialization of next-generation therapeutic products addressing obesity and sexual health, today announced that it has entered into a purchase agreement with two institutional investors for the sale of $12 million of its common stock in a registered direct offering.

Yahoo News (http://biz.yahoo.com/prnews/060510/sfw053.html?.v=56)